GSK, Microsoft partner with CHDS Nepal on disease surveillance project
The pilot project brings together expertise in biopharma and technology to improve regional health interventions and expedite the…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
22 Sep 22
The pilot project brings together expertise in biopharma and technology to improve regional health interventions and expedite the…
21 Sep 22
The transaction, which has been unanimously approved by the boards of directors of both the companies, is expected…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
21 Sep 22
Whether a Covid-19 infection can cause health risks and chronic performance issues for athletes will be made clearer…
21 Sep 22
Pfizer has used CytoReason's biological models in its research to improve the understanding of the immune system and…
20 Sep 22
The EC approval of Vabysmo is supported by positive results from four Phase 3 studies, including TENAYA and…
20 Sep 22
Through the deal, GENFIT will gain access to VS-01, a liposomal-based drug candidate for the treatment of acute-on-chronic…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
19 Sep 22
The trial showed that the proposed biosimilar matched the reference product on the basis of pharmacokinetics, efficacy, pharmacodynamics,…
19 Sep 22
According to the firm, Skysona is the only FDA-approved treatment to decrease the course of neurologic deterioration in…
16 Sep 22
According to the competition watchdog, Novartis allegedly misused its patent rights to reduce competitive pressure on its skin…
16 Sep 22
The enlarged RIGImmune with the addition of Subintro will focus on advancing the development of novel RNA therapies…